Patient Assistance Programs
 
Fighting AIDS in Africa
 
Bristol-Myers Squibb Foundation & Corporate Philanthropy
 
Product Integrity
 
Sustainability: Our Plan for Responsible Growth
 
Environment, Health & Safety Policy
 
Medical Education Grants And Charitable Contributions
 
Clinical Outcomes And Research Grants
 
Position On Key Issues

 

  » BMS.com Home » Corporate Responsibility » Scholars in Autoammunity
SEARCH INDEX

Scholars in Autoimmunity

Bristol-Myers Squibb is pleased to announce the availability of a new scholarship program for 2008 entitled, Scholars in Autoimmunity.  The program is designed to recognize fellows specializing in autoimmune diseases through the award of a $500 scholarship to pay for registration, travel or other fees associated with attending key relevant congresses including American College of Rheumatology (ACR) or American College of Gastroenterology (ACG).  Institutions with fellowship training programs in autoimmune disease may apply for the scholarships.  After receipt of the scholarship application’s approval, the institution will select the scholarship recipient of its choice based on the criteria set forth in the agreement between the institution and Bristol-Myers Squibb.  The selection of the scholarship winner should be based upon the fellow’s research experience, patient care, and academic excellence.  If your institution wishes to submit an application for a scholarship, please use the BMS online application form available at:

www.scholarslink.org

Applications will be accepted for review until 5:00PM on July 15, 2008. Please note that any applications received will not be reviewed until after this date.

 

 

 

 




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

Our Medical Grants and Charitable Contributions program supports educational initiatives.
SEARCH INDEX